At the LL&M APP Institute, you're not just attending another conference, you're stepping into a community of Advanced Practice Providers who live the same challenges, celebrate the same wins, and share your passion for patient-centered care. This is your space to: • Build

As we mark the 25th anniversary of the LL&M Congress, we’re reflecting on the milestones, connections, and clinical insights that have shaped a quarter century of progress. We want to hear from you: What’s your most memorable LL&M Congress moment? Whether it was a pivotal

Only 4 days left to submit your abstract for the 25th Annual LL&M Congress, happening October 14–17, 2025, in NYC! Share your breakthroughs in hematologic malignancies and join a global community of 1,000+ oncology professionals. Why submit? ✅ Present your research to top

🩸 SUBMISSION DEADLINE EXTENDED- NEW DEADLINE JULY 31ST! There’s still time to share your research with one of the largest audiences in hematologic oncology. Submit your abstract to #LLMCongress25 and be part of a 25-year legacy of clinical innovation and collaboration.

The LL&M APP Institute delivers focused, real-world education built exclusively for Advanced Practice Providers in hematology-oncology. This one-day program brings you into the heart of what matters most in cancer care today, including: - Precision Medicine in Hematologic

You’ve put in the work. Now give your research the audience it deserves. The Lymphoma, Leukemia & Myeloma Congress is accepting abstracts for its 25th anniversary meeting. Selected authors will present to 1,000+ clinicians, gain national recognition, and be published in the

Join us for the 25th Annual LL&M Congress, October 14–17, 2025, in New York City, where the global hematology-oncology community convenes to explore the latest advances in the diagnosis, treatment, and management of blood cancers. From frontline therapies to novel mechanisms and

Tomorrow's the last day to submit your abstracts and present your research at the 25th Annual LL&M Congress, October 14–17, 2025 in NYC! Whether you're exploring novel therapies, clinical outcomes, or mechanisms in hematologic malignancies, this is your chance to: - Share your

You manage patients across diseases. Your education should reflect that. LL&M Congress brings four days of lymphoma, leukemia, and myeloma updates together into one integrated experience. Translated by expert faculty. Clinically focused. Immediately applicable. Early rate

Not every hematologic abnormality signals malignancy. But some benign-looking findings warrant anything but reassurance. At this year’s LL&M Congress, Dr. Pinkal Desai will explore the emerging landscape of clonal marrow conditions and how they are reshaping our understanding

We see you, advanced practice providers 👀 Overwhelmed by rapid developments. Searching for role-specific guidance. What do you need now? Focused, fast-paced education that is (actually) designed for you. This October in the big apple, experience two incredible events built for

138 of you said, “I have something to say.” And you said it loud and clear with a record-breaking number of abstract submissions for this year's LLM Congress. That’s 138 voices. 138 ideas. 138 reasons this year’s event will be unlike any other. From global insights to local

From podium to practice—real insights from the leaders shaping the future of hematologic care. Join us at the 25th Annual Lymphoma, Leukemia & Myeloma Congress, where over 75 renowned experts will present the latest clinical evidence, engage in high-level debates, and offer

There was a time when acute promyelocytic leukemia (APL) was one of the deadliest leukemias. Marked by sudden onset, high risk of early complications, and devastating outcomes. But medicine doesn’t stand still. Thanks to the introduction of all-trans retinoic acid (ATRA) and

Better education leads to better outcomes—because every insight you gain can make a difference in someone’s life. ❤️ At the 25th Annual Lymphoma, Leukemia & Myeloma Congress, we’re not just delivering updates, we’re empowering hematology and oncology professionals with the

Follicular lymphoma has long carried a reputation: incurable, slow-growing, and often managed with watchful waiting. But what if that reputation is outdated? At the LL&M Congress this October, Dr. Jonathan Friedberg will make the case for rethinking everything we’ve assumed

For patients with MGUS or smoldering myeloma, the stakes are high—but the signs aren’t always clear. It’s a question that keeps even the most experienced hematologists up at night: Who needs to be monitored closely? Who needs treatment now? At LL&M Congress, Dr. Irene Ghobrial

You change lives—let us empower your practice. Every day, hematology and oncology professionals like you make critical decisions that shape patient journeys. The LL&M Congress is here to support that mission with the most comprehensive, clinically relevant education in blood